Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.

CONTEXT Quality indicators for the treatment of acute myocardial infarction include pharmacologic therapy, reperfusion, and smoking cessation advice, but these therapies may not be administered to all patients who could benefit from them. OBJECTIVE To assess geographic variation in adherence to quality indicators for treatment of acute myocardial infarction. DESIGN Inception cohort using data from the Health Care Financing Administration Cooperative Cardiovascular Project. SETTING Acute care hospitals in the United States. PATIENTS A total of 186800 Medicare beneficiaries hospitalized for treatment of confirmed acute myocardial infarction from February 1994 through July 1995. MAIN OUTCOME MEASURES Adherence to quality indicators for pharmacologic therapy, reperfusion, and smoking cessation advice for patients judged to be ideal candidates for these therapies. The mean rates of adherence to these quality indicators for the entire United States were determined, and the 20th and 80th percentiles of the age- and sex-adjusted rates for each of 306 hospital referral regions were contrasted (mean rate [20th-80th percentiles]). RESULTS Aspirin was used frequently both during hospitalization (86.2% [82.6%-90.1%]) and at discharge (77.8% [72.5% -83.9%]). Calcium channel blockers were withheld from most patients with impaired left ventricular function (81.9% [73.6%-90.8%]). Lower rates were seen in the use of angiotensin-converting enzyme inhibitors at discharge (59.3% [49.2%-69.2%]); reperfusion, using thrombolytic therapy or coronary angioplasty (67.2% [59.8%-75.1%]); prescription of beta-blockers at discharge (49.5% [35.8%-61.5%]); and for smoking cessation advice (41.9% [32.8%-51.3%]). CONCLUSIONS Substantial geographic variation exists in the treatment of patients with acute myocardial infarction, and these gaps between knowledge and practice have important consequences. Therapies with proven benefit for AMI are underused despite strong evidence that their use will result in better patient outcomes.

[1]  Stephen B. Soumerai,et al.  Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction: A Randomized Controlled Trial , 1999 .

[2]  Harlan M. Krumholz,et al.  Improving the Quality of Care for Medicare Patients with Acute Myocardial Infarction: Results from the Cooperative Cardiovascular Project , 1999 .

[3]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[4]  Russell S. Kirby,et al.  The Dartmouth Atlas of Health Care , 1998 .

[5]  R. Kanigel The One Best Way: Frederick Winslow Taylor and the Enigma of Efficiency , 1998 .

[6]  E. Huff,et al.  Comprehensive reliability assessment and comparison of quality indicators and their components. , 1997, Journal of clinical epidemiology.

[7]  C. Albert,et al.  Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. , 1996, The New England journal of medicine.

[8]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[9]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[10]  Richard V. Milani,et al.  Regional Variation Across the United States in the Management of Acute Myocardial Infarction , 1996 .

[11]  L Pilote,et al.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.

[12]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[13]  S. Yusuf,et al.  Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.

[14]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[15]  S. Flocke,et al.  Family physicians' disagreements with the US Preventive Services Task Force recommendations. , 1994, The Journal of family practice.

[16]  Wasson Jh,et al.  Leading clinical quality improvement. Using patient-based information to rapidly redesign care. , 1994 .

[17]  H. Rubin,et al.  Internists' Attitudes about Clinical Practice Guidelines , 1994, Annals of Internal Medicine.

[18]  P B Batalden,et al.  Linking outcomes measurement to continual improvement: the serial "V" way of thinking about improving clinical care. , 1994, The Joint Commission journal on quality improvement.

[19]  E. Nelson,et al.  Leading clinical quality improvement. Using patient-based information to rapidly redesign care. , 1994, The Healthcare Forum journal.

[20]  E. DeLong,et al.  Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.

[21]  G. Lamas,et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.

[22]  S. Jencks,et al.  The health care quality improvement initiative. A new approach to quality assurance in Medicare. , 1992, JAMA.

[23]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[24]  J Z Ayanian,et al.  Differences in the use of procedures between women and men hospitalized for coronary heart disease. , 1991, The New England journal of medicine.

[25]  A M Epstein,et al.  The association of payer with utilization of cardiac procedures in Massachusetts. , 1990, JAMA.

[26]  F. Klocke,et al.  Guidelines for the early management of patients with acute myocardial infarction , 1990 .

[27]  F. Klocke,et al.  ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.

[28]  A. Epstein,et al.  Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. , 1989, JAMA.

[29]  D M Berwick,et al.  Continuous improvement as an ideal in health care. , 1989, The New England journal of medicine.

[30]  L I Iezzoni,et al.  Coding of acute myocardial infarction. Clinical and policy implications. , 1988, Annals of internal medicine.

[31]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[32]  R H Brook,et al.  Variations in the use of medical and surgical services by the Medicare population. , 1986, The New England journal of medicine.

[33]  A. Gittelsohn,et al.  Small Area Variations in Health Care Delivery , 1973, Science.